Clinical Study Of Sensor Augmented Insulin Pump For Diabetic Pations In Perioperative Period

Objective: Compare clinical effects of Sensor Augmented insulin Pumptherapy(SAP) and continuous subcutaneous insulin injection(CSII) in diabeticpatients of perioperative period. And evaluate the former value in the clinicalapplication by comparing the complications that two cases occurred.Methods: Two hundred and twenty diabetic patients in perioperative periodwere divided into observation group （90cases）and control group (130cases).Observation group with the use of Sensor Augmented insulin Pump (SAP group), thecontrol group patients with continuous subcutaneous insulin infusion therapy byusing insulin pump(CSII group). The changes of some clinical indexes(the incidenceof hypoglycemia, the infection rate of operative incisions, the duration to achieve thetarget for blood glucose, the time of preoperative preparation, the time ofpreoperative disconnection, the length of hospitalization, mean fluctuations extent ofblood glucose, insulin dosage and total expense of hospitalization, educationalguidance time was given by medical personnel in the SAP group when diabeticpatients with insulin pump, the number of the consultation and alarms needinghandled by health care during the period when diabetic patients with insulin pump)were compared between the two groups before and after the treatment.Results: The incidence of hypoglycemia, the infection rate of operativeincisions in the SAP group were obviously lower than those in the CSII group(p<0.01); The duration to achieve the target for blood glucose, the time of preoperativepreparation, the time of preoperative disconnection, the length of hospitalization wereobviously shorter than those in the CSII group(p<0.05); Mean fluctuations extent ofblood glucose in the SAP group were obviously lower than those in the CSIIgroup(p<0.05); Insulin dosage and total expense of hospitalization in SAP group wasalmost as much as that in CSII(p>0.05); The educational guidance time was given bymedical personnel in the SAP group when diabetic patients with insulin pump was significantly longer compared to CSII group (p<0.01); the number of the consultationand alarms needing handled by health care during the period when diabetic patientswith insulin pump significantly increased compared to the CSII group (p <0.01).Conclusion:SAP is superior to CSII at clinical effects and safety for diabeticpatients in perioperative period. compared to lifelong treatment in blood glucosecontrol of diabetic patients, security of diabetic patients in perioperative period is ashort-term process, in this short course of treatment, although the more number oftimes of rounds, and more time and effort which health care workers need to invest,but brought great benefits to diabetic patients with surgical treatment. Because thepresent, the world’s most advanced treatment methods do not increase the amount ofinsulin and the patient’s total costs of health care and also significantly improvedperioperative glycemic compliance rate, better results of glycemic control, reducingsignificantly the occurrence of hypoglycemia and risk of surgery to help the majorityof diabetic patients successfully spending perioperative period, there is a high clinicalvalue.